Practical case studies will allow you to have interaction with complex situations of routine consultation of degenerative and infectious pathologies”

The current sociodemographic situation in much of the world shows an increase in the elderly population and life expectancy in contrast to the reduction of the birth rate. For this reason, the presence of geriatric patients in health systems is common, who also require, due to their special characteristics in the biological, psychological and social spheres, comprehensive care to meet their needs.  

Therefore, the approach to the main pathologies from this perspective facilitates increased quality and efficiency of care. In this sense, it is essential for medical professionals to be aware of diagnostic and therapeutic advances in the main pathologies of this age group. For this reason, TECH has designed this Professional master’s degree in Geriatric Rheumatology that offers a complete syllabus prepared by real experts in this field with extensive experience in leading hospitals.  

This is a program of 1,500 teaching hours, where the graduate, through multimedia didactic material, complementary readings and simulations of clinical case studies, will delve into aging, the most frequent diseases that affect the locomotor system, as well as the advances in imaging techniques for diagnosis and pharmacological and non-pharmacological treatments. 

Everything, moreover, from a theoretical-practical perspective and a pedagogical methodology that moves away from long hours of study. Thanks to the Relearning system, based on the continuous reiteration of key concepts, students will consolidate them in a much simpler way. 

Undoubtedly, an exceptional opportunity to keep up-to-date with the management of rheumatologic conditions without the need to attend centers in person, or to have sessions with fixed schedules. In this way, the specialist is faced with a flexible and convenient university program. They only need an electronic device (cell phone, tablet or computer) with internet connection to visualize, at any time of the day, the syllabus of this advanced academic option.  

Practical case studies will allow you to have interaction with complex situations of routine consultation of degenerative and infectious pathologies”

This Professional master’s degree in Geriatric Rheumatology contains the most complete and up-to-date scientific program on the market. The most important features include:

• The development of case studies presented by experts in rheumatology
• The graphic, schematic, and practical contents with which they are created, provide scientific and practical information on the disciplines that are essential for professional practice
• Practical exercises where self-assessment can be used to improve learning
• Its special emphasis on innovative methodologies  
• Theoretical lessons, questions to the expert, debate forums on controversial topics, and individual reflection assignments 
• Content that is accessible from any fixed or portable device with an Internet connection 

TECH has designed a program for professionals like you with high responsibilities and eager to update your knowledge with the best specialists”

The program’s teaching team includes professionals from the field who contribute their work experience to this educational program, as well as renowned specialists from leading societies and prestigious universities.  

Its multimedia content, developed with the latest educational technology, will allow the professional a situated and contextual learning, that is, a simulated environment that will provide an immersive education programmed to learn in real situations.  

This program is designed around Problem-Based Learning, whereby the professional must try to solve the different professional practice situations that arise during the academic year For this purpose, the students will be assisted by an innovative interactive video system created by renowned and experienced experts. 

Delve into the latest clinical developments in pain treatments with Platelet Rich Plasma and Mesenchymal Stem Cells"

In order to promote a complete update in Geriatric Rheumatology, the specialized teaching team of this program has designed a syllabus that deals in depth with the differential aspects of geriatric patients from the point of view of molecular biology, genetics and physiology. Moreover, thanks to the numerous additional didactic resources, you will be able to update your knowledge on an individual basis for each of the different groups of rheumatic pathologies. All this with a virtual library accessible 24 hours a day from any digital device with an Internet connection. 

Integrate into your daily practice the most recent treatments to address pathologies of bone metabolism”

Module 1. Specific characteristics of the geriatric patient 

1.1. Physiology of aging 

1.1.1. Aging 
1.1.2. Biological process of aging 

1.2. Demography and epidemiology of aging 

1.2.1. Aging in Spain and the rest of the world
1.2.2. Morbimortality in the elderly population and new challenges

1.3. Longevity and life expectancy 

1.3.1. Senescence processes and possible pathways of regulation
1.3.2. Healthy aging 

1.4. Disease in the elderly 

1.4.1. Intrinsic capacity, frailty and functional continuum 
1.4.2. Acute, chronic and multimorbidity disease 
1.4.3. Specialized geriatric care 

1.5. Pharmacotherapy in the elderly patient 

1.5.1. Pharmacokinetic and pharmacodynamic modifications
1.5.2. Pharmacovigilance 
1.5.3. Prescription quality 

1.6. Medical assessment and complementary tests in the elderly patient 

1.6.1. Medical History 
1.6.2. Physical Examination 
1.6.3. Complementary Tests 

1.7. Comprehensive geriatric assessment (CGA) 

1.7.1. Components of the IGV 
1.7.2. Instruments used in IGV 

1.8. Geriatric syndromes (GS) 

1.8.1. Characteristics of GS 
1.8.2. Classification and prevalence of GS 
1.8.3. Recommendations for the preventive and therapeutic management of SGs 

1.9. Aging and physical exercise 

1.9.1. Neuromuscular system and aging 
1.9.2. Cardiovascular function, physical exercise and aging 
1.9.3. Biomechanics and mobility assessment 

1.10. Health care of the elderly patient 

1.10.1. Levels of care and social resources 
1.10.2. Management and quality of care in health care for the elderly 

Module 2. Pathology of bone metabolism 

2.1. Bone metabolism in the geriatric patient

2.1.1. Osteoporosis 
2.1.2. Importance of osteoporosis in the elderly. Special characteristics of the geriatric patient 

2.2. Epidemiology of bone metabolism pathologies

2.2.1. Most frequent bone diseases 
2.2.2. Epidemiology of bone diseases in the elderly

2.3. Molecular and cellular biology of bone metabolism 

2.3.1. Bone tissue. Bone remodeling. Acquisition of peak bone mass 
2.3.2. Bone formation/destruction imbalance in the elderly patient
2.3.3. Elderly patient: oxidative stress, osteoblast and osteocyte senescence, autophagy

2.4. Diagnostic techniques and interpretation 

2.4.1. Initial evaluation of the patient with osteoporosis 
2.4.2. Bone densitometry and its correct interpretation. FRAX®. Strengths and limitations 
2.4.3. Biochemical markers of bone remodeling

2.5. The importance of 25-hydroxyvitamin D 

2.5.1. Absorption and Metabolism 
2.5.2. Optimal level of 25-hydroxyvitamin D. Daily requirements 
2.5.3. Deficit and Excess of 25-hydroxyvitamin D 

2.6. Pathologies due to a decrease in bone mineral density 

2.6.1. Previous key concepts 
2.6.2. Osteomalacia 

2.7. Pathologies due to increased bone mineral density 

2.7.1. DISH. Diffuse idiopathic skeletal hyperostosis 
2.7.2. Paget's disease of bone 

2.8. Other Bone Diseases 

2.8.1. Osteonecrosis. Avascular necrosis of the hip
2.8.2. Sympathetic Reflex Dystrophy 
2.8.3. Renal osteodystrophy 

2.9. Treatment I: Prevention and non-pharmacological measures 

2.9.1. Physical activity and exercise in the elderly patient 
2.9.2. Geriatric nutrition: Nutritional problems in older adults 
2.9.3. Calcium and vitamin D supplementation 

2.10. Treatment II: Pharmacology 

2.10.1. Types of Drugs Antiresorptive and osteoformers
2.10.2. Combined therapy vs. sequential therapy 
2.10.3. Special Situations 

Module 3. Chronic inflammatory joint diseases (arthritis/spondyloarthritis) 

3.1. Molecular biology and pathophysiology of chronic inflammatory joint diseases

3.1.1. Genomic studies in chronic inflammatory joint diseases  

3.2. Inflammation and chronicity in the geriatric patient 

3.2.1. The inflammatory process: mechanisms of production 
3.2.2. Chronic inflammation in the geriatric patient 
3.2.3. Immunosenescence 

3.3. Epidemiological characteristics of chronic joint diseases 

3.3.1. Epidemiology of Rheumatoid Arthritis 
3.3.2. Epidemiology of Spondyloarthritis 

3.4. Diagnostic techniques in inflammatory joint diseases 

3.4.1. Utility of the blood analysis: general analysis, serum markers, autoantibodies
3.4.2. Synovial fluid analysis 
3.4.3. Imaging techniques: simple radiology, musculoskeletal ultrasound, other imaging studies 

3.5. Extra-articular manifestations (uveitis, Diffuse Interstitial Pulmonary Interstitial Disease: EPID, Inflammatory Bowel Disease, etc.)

3.5.1. Ocular Manifestations 
3.5.2. Pulmonary manifestations: PIDD 
3.5.3. Gastrointestinal manifestations associated with chronic inflammatory joint diseases (IBD) 
3.5.4. Cutaneous manifestations 
3.5.5. Other extra-articular manifestations 

3.6. Rheumatoid arthritis in the geriatric population 

3.6.1.  Epidemiology and Etiopathogenesis 
3.6.2. Clinical Diagnosis 
3.6.3. Treatment 

3.7. Spondyloarthritis in geriatric patients 

3.7.1. Epidemiology, etiopathogenesis and classification
3.7.2. Clinical Diagnosis 
3.7.3. Treatment  

3.8. Seronegative arthritis 

3.8.1. Classification 
3.8.2. Treatment 

3.9. Synthetic disease-modifying medications 

3.9.1. Classification 
3.9.2. Indications and dosage 
3.9.3. Adverse effects and interactions in the pluripathologic and polymedicated elderly patient 

3.10. Disease-modifying drugs: biologic therapy and small molecules

3.10.1. Classification 
3.10.2. Indications and dosage 
3.10.3. Adverse effects and interactions in the pluripathologic and polymedicated elderly patient 

Module 4. Connectivopathologies: characteristics, manifestations and specific care in the geriatric patient

4.1. Systemic lupus erythematosus: clinical differences and diagnostic challenges in the geriatric population

4.1.1. Introduction  
4.1.2. Etiopathogenesis and epidemiology of SLE in the geriatric patient 
4.1.3. Diagnosis of SLE in the geriatric patient 
4.1.4. Clinical and immunologic features of senile SLE 

4.2. Treatment of non-renal systemic lupus erythematosus erythematosus senilis 

4.2.1. Non-pharmacological methods 
4.2.2. Pharmacological Methods 

4.3. Treatment of non-renal systemic lupus erythematosus erythematosus senilis 

4.3.1. Non-pharmacological methods 
4.3.2. Pharmacological Methods 

4.4. Antiphospholipid syndrome (APS): clinical differences, diagnostic challenges and treatment in the geriatric population

4.4.1.  Introduction  
4.4.2. Etiopathogenesis and epidemiology of APS in the geriatric patient
4.4.3. Diagnosis of APS in the geriatric patient 
4.4.4. Clinical characteristics and peculiarities of APS in the geriatric population

4.5. Treatment of APS in geriatric patients 

4.5.1. Non-pharmacological methods 
4.5.2. Pharmacological Methods 
4.5.3. Catastrophic PAS 

4.6. Scleroderma: clinical differences and diagnostic challenges in the geriatric population 

4.6.1. Introduction 
4.6.2. Aetiopathogenesis and epidemiology of scleroderma in the geriatric patient 
4.6.3. Raynaud's disease. Peculiarities in geriatric population and differential diagnosis
4.6.4. Diagnosis and clinical features of scleroderma in the geriatric patient

4.7. Scleroderma: peculiarities of the treatment in the geriatric population 

4.7.1. Management of Raynaud's 
4.7.2. Pharmacological Methods 

4.8. Senile Sjögren's syndrome: clinical differences and diagnostic challenges in the geriatric population 

4.8.1. Introduction  
4.8.2. Etiopathogenesis and epidemiology of Sjögren's syndrome in the geriatric patient
4.8.3. Diagnosis of Sjögren's in the geriatric patient, Is all dryness due to Sjögren's syndrome? 
4.8.4. Clinical and immunologic features of senile SLE 
4.8.5. Lymphoma and Sjögren's 

4.9. Treatment of Sjögren's disease in the geriatric population and its peculiarities 

4.9.1. Glandular manifestations 
4.9.2. Extraglandular manifestations 

4.10. Undifferentiated connective tissue disease (UCTD) and Mixed Connective Tissue Disease (MCTD) in the geriatric population

4.10.1. Introduction 
4.10.2. Etiopathogenesis and epidemiology of CITD and MCTD 
4.10.3. Diagnosis and clinical features in the geriatric patient 
4.10.4. Treatment of CTE and CTEMS in the geriatric population  

Module 5. Musculoskeletal manifestations of systemic pathologies of the elderly (IR, hepatic I, anemias, parathyroid pathology) and other metabolic atroparias

5.1. Microcrystalline arthropathies: features 

5.1.1. Epidemiology 
5.1.2. Pathogenesis
5.1.3. Types  

5.2. Microcrystalline arthropathies: diagnosis 

5.2.1. Pathophysiology  
5.2.2. Differential Diagnosis  

5.3. Microcrystalline arthropathies: treatment 

5.3.1. Treatment  
5.3.2. Prevention of new episodes  

5.4. Renal diseases and their musculoskeletal manifestations 

5.4.1. Epidemiology  
5.4.2. Physiopathogenesis  
5.4.3. Treatment  

5.5. Hepatic Diseases and their musculoskeletal manifestations 

5.5.1. Musculoskeletal manifestations of HCV  
5.5.2. Cryoglobulinemia  

5.6. Non-neoplastic hematologic diseases and their musculoskeletal manifestations 

5.6.1. Multiple Myeloma Monoclonal Gammopathy of Uncertain Significance (MGUS)
5.6.2. Hemophilia 

5.7. Endocrinologic diseases and musculoskeletal manifestations 

5.7.1. Diabetes Mellitus 
5.7.2. Thyroid Disease 

5.8. Wilson's disease, hemochromatosis, mucopolysaccharidosis 

5.8.1. Wilson's disease: etiopathogenesis, clinical features, diagnosis and treatment
5.8.2. Hereditary hemochromatosis: etiopathogenesis, clinical features, diagnosis and treatment
5.8.3. Mucopolysaccharidosis: etiopathogenesis, clinical features, diagnosis and treatment

5.9. Rheumatic diseases with cutaneous involvement: Panniculitis 

5.9.1. Epidemiology  
5.9.2. Pathophysiology  
5.9.3. Treatment 

5.10. Enteropathic arthritis 

5.10.1. Coeliac Disease
5.10.2. Collagenous colitis  
5.10.3. Whipple's disease 

Module 6. Neoplastic and Paraneoplastic Pathology 

6.1. Oncogeriatrics 

6.1.1. Initial assessment of the geriatric oncology patient 
6.1.2. Oncologic treatments in geriatric patients 

6.2. Paraneoplastic Syndromes 

6.2.1. Epidemiology, etiology and classification
6.2.2. Prognosis and differential diagnosis of paraneoplastic syndromes 

6.3. Management of paraneoplastic pathology 

6.3.1. Treatment of paraneoplastic syndromes 
6.3.2. Follow-up of paraneoplastic syndromes 

6.4. Joint tumors 

6.4.1. Epidemiology, diagnosis and classification 
6.4.2. Multidisciplinary management 

6.5. Primary and metastatic bone tumors 

6.5.1. Epidemiology, diagnosis and classification 
6.5.2. Multidisciplinary management 

6.6. Amyloidosis 

6.6.1. Epidemiology and types 
6.6.2. AL amyloidosis: Therapeutic management 

6.7. Rheumatic manifestations of chemotherapeutic treatments 

6.7.1. Dermatologic toxicities secondary to systemic treatments 
6.7.2. Management of dermatological toxicities secondary to systemic treatments 

6.8. Immune-mediated side effects/diseases in the musculoskeletal system secondary to immunotherapy 

6.8.1. Side effects to checkpoint inhibitors 
6.8.2. Cellular immunotherapy toxicity: vectors, TILs, CAR-Tç cells

6.9. Cancer Pain 

6.9.1. Incidence, types, classification 
6.9.2. Management of oncologic pain 

6.10. Pathologic bone fractures in oncologic patients 

6.10.1. Incidence, causes 
6.10.2. Management of pathologic bone fracture in oncology patients 

Module 7. Degenerative and infectious pathology 

7.1. Arthrosis 

7.1.1. Etiopathogenesis. Primary and Secondary Arthrosis 
7.1.2. Role of non-osseous structures in osteoarthritis
7.1.3. Molecular biology of osteoarthritis 

7.2. Diagnostic techniques for osteoarthritis 

7.2.1. Reality of the techniques that we ask for in the consultation room 
7.2.2. From conventional radiography to nuclear medicine 
7.2.3. Other Techniques 

7.3. Musculoskeletal deterioration associated with age. Fractures in the elderly 

7.3.1. Age-associated musculoskeletal pathophysiology: sarcopenia and osteopenia
7.3.2. Epidemiology and socioeconomic cost 
7.3.3. Most frequent fractures in the emergency and consultation room 

7.4. Fractures of the pelvis and hip in the elderly 

7.4.1. Epidemiology Socioeconomic implications and public health problems
7.4.2. Diagnosis and Classification 
7.4.3. Treatment 

7.5. Degenerative and traumatic pathology of the elderly spine 

7.5.1. Characteristics and pathophysiology of aging at the level of the spine
7.5.2. Specific fractures of geriatric age 
7.5.3. Degenerative pathology of the disc, joints and canal 
7.5.4. Therapy Options 

7.6. Other arthropathies 

7.6.1. Neuropathic arthropathy
7.6.2. Hemorrhagic arthropathy 
7.6.3. Other arthropathic disorders 

7.7. General information on the treatment of osteoarthritis 

7.7.1. Conservative Treatment 
7.7.2. Surgical treatment with joint preservation 
7.7.3. Prosthetic treatment 

7.8. Musculoskeletal infections 

7.8.1. Soft Tissue Infections 
7.8.2. Bone infections: Osteomyelitis 
7.8.3. Joint infections 
7.8.4. Implant infections 

7.9. Soft Tissue Injuries 

7.9.1. Traumatic and inflammatory muscle injuries 
7.9.2. Degenerative, traumatic and inflammatory injuries at the tendon level 
7.9.3. Pathology of the synovial bursa 

7.10. Joint trauma 

7.10.1. Contusions 
7.10.2. Sprains 
7.10.3. Dislocation 

Module 8. Vasculitis, myopathies and other systemic diseases 

8.1. Chronic idiopathic inflammatory myopathies

8.1.1. Characteristics and classification 
8.1.2. Treatment, evolution and prognosis 

8.2. Vasculitis 

8.2.1. Epidemiology 
8.2.2. Classification 

8.3. Large vessel vasculitis 

8.3.1. Giant cell arteritis and polymyalgia rheumatica
8.3.2. Takayasu's Arteritis 

8.4. Polyarteritis nodosa 

8.4.1. Epidemiology 
8.4.2. Clinical Manifestations 
8.4.3. Treatment 

8.5. Immunocomplex-mediated small-vessel vasculitis 

8.5.1. Hypersensitivity vasculitis 
8.5.2. IgA vasculitis 
8.5.3. Cryoglobulinemic Vasculitis 
8.5.4. Hypocomplementemic urticarial vasculitisi 

8.6. ANCA-positive vasculitis 

8.6.1. Granulomatosis with polyangiitis (Wegener's granulomatosis) 
8.6.2. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss disease)
8.6.3. Microscopic polyangiitis 
8.6.4. Treatment of ANCA-positive vasculitis 

8.7. Miscellaneous 

8.7.1. Behçet's Disease 
8.7.2. Relapsing Polychondritis 
8.7.3. Single organ vasculitis 

8.8. Pseudovasculitic syndromes: Vasculitis associated systemic disease 
8.9. Sarcoidosis from the rheumatologic point of view 

8.9.1. Clinical Manifestations 
8.9.2. Diagnosis and Treatment 

8.10. Adult Still's Disease 

8.10.1. Epidemiology 
8.10.2. Clinical Manifestations 
8.10.3. Diagnosis and Treatment 

Module 9. Pain of rheumatic origin in the geriatric patient

9.1. Pathophysiology of Pain 

9.1.1. The transmission of pain. Nociceptors. Inflammatory Mediators 
9.1.2. Peripheral sensitization, nociceptive modulation
9.1.3. Pathophysiology of Neuropathic Pain 

9.2. Anatomy of pain 

9.2.1. Anatomical substrate of nociceptive transmission 

9.3. Epidemiology of pain in geriatric patients 

9.3.1. Factors involved in pain 

9.4. Treatment: prevention and modification of harmful habits 

9.4.1. Quality of life assessment measures 
9.4.2. Assessment of function, cognitive and psychological aspects 
9.4.3. Prevention of sedentary lifestyles and inactivity. Health education 

9.5. Non-pharmacological treatment: Interventions in the biopsychosocial field

9.5.1. Initial clinical evaluation 
9.5.2. Health education and general recommendations 
9.5.3. Symptomatic treatments: Kinesitherapy and electrotherapy 

9.6. Physical therapy for degenerative pathology 

9.6.1. Electrotherapy, kinesitherapy and hydrotherapy 
9.6.2. Occupational therapy, orthotics and technical aids 
9.6.3. Evidence-Based Medicine 

9.7. Physical therapy for inflammatory pathology 

9.7.1. Physical therapy and kinesitherapy 
9.7.2. Occupational therapy, orthotics and technical aids 
9.7.3. Evidence-based medicine 

9.8. Medical Treatment 

9.8.1. Therapeutic arsenal and its indications 
9.8.2. New developments in the clinic 

9.9. Interventional techniques in the geriatric patient 

9.9.1. Axial Interventionism 
9.9.2. Peripheral Interventionism 

9.10. Regenerative Medicine in the treatment of pain in the geriatric population 

9.10.1. Platelet Rich Plasma 
9.10.2. Mesenchymal Stem Cells 

Module 10. Common problems in geriatric patients 

10.1. Comorbidities. How do they affect treatment? 

10.1.1. Pluripathology and prognostic indices
10.1.2. Clinical management recommendations for patients with multiple pathologies

10.2. Management of polypharmacy (interactions) 

10.2.1. Concept of polypharmacy. Associated Factors
10.2.2. Pharmacotherapeutic optimization: appropriateness, reconciliation, interactions, deprescription, adherence to treatment

10.3. Nutrition in the elderly patient 

10.3.1. Malnutrition in the elderly. Screening of nutritional status 
10.3.2. Nutritional Treatment 

10.4. Physical activity in the elderly patient 

10.4.1. Chronic diseases and exercise 
10.4.2. Multicomponent training 

10.5. Vaccination of the geriatric patient 

10.5.1. General vaccination recommendations 
10.5.2. Other vaccines according to medical conditions 

10.6. Prophylactic treatments in geriatric patients 

10.6.1. Latent tuberculosis 
10.6.2. Osteoporosis 
10.6.3. Recurrent infections 

10.7. Health care facilitation tools 

10.7.1. Continuity of care. Integrated care process 
10.7.2. Communication tools: telephone consultation, e-consultation, videocall 

10.8. Geriatric nursing in rheumatology 

10.8.1. Pain assessment in older adults with rheumatologic problems 
10.8.2. Frailty in older adults 

10.9. Study design in Rheumatology 

10.9.1. Special characteristics of the geriatric population 
10.9.2. Advantages and disadvantages of the different designs in the geriatric population 

10.10. Data analysis in rheumatology 

10.10.1. Description of data in geriatrics 
10.10.2. Data analysis models 

You have at your disposal a virtual library with a wealth of innovative educational material, accessible 24 hours a day”